Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.
Blood Adv. 2023 Jan 24;7(2):236-245. doi: 10.1182/bloodadvances.2022007496.
Blood Adv. 2023.
PMID: 36251745
Free PMC article.
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy.
Muz B, Azab F, Fiala M, King J, Kohnen D, Fogler WE, Smith T, Magnani JL, Vij R, Azab AK.
Muz B, et al.
Blood Cancer J. 2019 Aug 20;9(9):68. doi: 10.1038/s41408-019-0227-3.
Blood Cancer J. 2019.
PMID: 31431613
Free PMC article.
No abstract available.
Item in Clipboard
Evolution and structure of clinically relevant gene fusions in multiple myeloma.
Foltz SM, Gao Q, Yoon CJ, Sun H, Yao L, Li Y, Jayasinghe RG, Cao S, King J, Kohnen DR, Fiala MA, Ding L, Vij R.
Foltz SM, et al. Among authors: kohnen dr.
Nat Commun. 2020 May 29;11(1):2666. doi: 10.1038/s41467-020-16434-y.
Nat Commun. 2020.
PMID: 32471990
Free PMC article.
Item in Clipboard
Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma.
Sun J, Muz B, Alhallak K, Markovic M, Gurley S, Wang Z, Guenthner N, Wasden K, Fiala M, King J, Kohnen D, Salama NN, Vij R, Azab AK.
Sun J, et al.
Cancers (Basel). 2020 Jan 28;12(2):305. doi: 10.3390/cancers12020305.
Cancers (Basel). 2020.
PMID: 32012878
Free PMC article.
Item in Clipboard
Co-evolution of tumor and immune cells during progression of multiple myeloma.
Liu R, Gao Q, Foltz SM, Fowles JS, Yao L, Wang JT, Cao S, Sun H, Wendl MC, Sethuraman S, Weerasinghe A, Rettig MP, Storrs EP, Yoon CJ, Wyczalkowski MA, McMichael JF, Kohnen DR, King J, Goldsmith SR, O'Neal J, Fulton RS, Fronick CC, Ley TJ, Jayasinghe RG, Fiala MA, Oh ST, DiPersio JF, Vij R, Ding L.
Liu R, et al. Among authors: kohnen dr.
Nat Commun. 2021 May 7;12(1):2559. doi: 10.1038/s41467-021-22804-x.
Nat Commun. 2021.
PMID: 33963182
Free PMC article.
Item in Clipboard
Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.
de la Puente P, Luderer MJ, Federico C, Jin A, Gilson RC, Egbulefu C, Alhallak K, Shah S, Muz B, Sun J, King J, Kohnen D, Salama NN, Achilefu S, Vij R, Azab AK.
de la Puente P, et al.
J Control Release. 2018 Jan 28;270:158-176. doi: 10.1016/j.jconrel.2017.11.045. Epub 2017 Nov 28.
J Control Release. 2018.
PMID: 29196043
Free PMC article.
Item in Clipboard
Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy.
Alhallak K, Sun J, Wasden K, Guenthner N, O'Neal J, Muz B, King J, Kohnen D, Vij R, Achilefu S, DiPersio JF, Azab AK.
Alhallak K, et al.
Leukemia. 2021 Aug;35(8):2346-2357. doi: 10.1038/s41375-021-01127-2. Epub 2021 Jan 21.
Leukemia. 2021.
PMID: 33479469
Free PMC article.
Item in Clipboard
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.
Federico C, Alhallak K, Sun J, Duncan K, Azab F, Sudlow GP, de la Puente P, Muz B, Kapoor V, Zhang L, Yuan F, Markovic M, Kotsybar J, Wasden K, Guenthner N, Gurley S, King J, Kohnen D, Salama NN, Thotala D, Hallahan DE, Vij R, DiPersio JF, Achilefu S, Azab AK.
Federico C, et al.
Nat Commun. 2020 Nov 27;11(1):6037. doi: 10.1038/s41467-020-19932-1.
Nat Commun. 2020.
PMID: 33247158
Free PMC article.
Item in Clipboard
Cite
Cite